Abstract

IntroductionEstrogen receptor(ER), progesterone receptor(PR) status and P53 has been known as a prognostic factor in endometrial cancer. The aim of this study is to analyze the significance of P53,ER,PR status...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
EP201/#746 Association between estrogen receptor/progesterone receptor status and risk factors in postmenopausal women with endometrioid type endometrial cancer
Minseong Choi ... Minjeong Park
International Journal of Gynecologic Cancer | VOL. 33
Minseong Choi, et. al.Minseong Choi ... Minjeong Park
01 Nov 2023
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer
H.W Nijman ... N Leffers
Gynecologic Oncology | VOL. 114
H.W Nijman, et. al.H.W Nijman ... N Leffers
02 May 2009
Association of Peritoneal Cytology with Other Prognostic Factors in Endometrial Cancer.
Tijana Vasiljević ... Tamara Maksimovic
Journal of cytology | VOL. 39
Tijana Vasiljević, et. al.Tijana Vasiljević ... Tamara Maksimovic
01 Jan 2021
Correlation Between Preoperative Serum CA 125 and Surgicopathologic Prognostic Factors in Endometrial Cancer
Elizabeth E Espino-Strebel ... Jericho Thaddeus P Luna
Gynecology & Obstetrics | VOL. 02
Elizabeth E Espino-Strebel, et. al.Elizabeth E Espino-Strebel ... Jericho Thaddeus P Luna
01 Jan 2012
View more papers

More From: International Journal of Gynecologic Cancer

Paper Title
Journal
Date
Author
Can international standards in ovarian cancer treatment be attained by low- and middle-income countries?
Daniel Sanabria ... Adriana Ramos
International Journal of Gynecologic Cancer | VOL. -
Daniel Sanabria, et. al.Daniel Sanabria ... Adriana Ramos
24 May 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
Eric Rios-Doria ... Mario M Leitao
International Journal of Gynecologic Cancer | VOL. -
Eric Rios-Doria, et. al.Eric Rios-Doria ... Mario M Leitao
23 May 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)
Agnieszka Michael ... Jonathan Ledermann
International Journal of Gynecologic Cancer | VOL. -
Agnieszka Michael, et. al.Agnieszka Michael ... Jonathan Ledermann
17 May 2024
Predictive value of SUVmax from initial 18F-FDG PET/CT scans for treatment outcomes in endometrial cancer patients undergoing fertility sparing management
Ok-Ju Kang ... Jeong-Yeol Park
International Journal of Gynecologic Cancer | VOL. -
Ok-Ju Kang, et. al.Ok-Ju Kang ... Jeong-Yeol Park
16 May 2024
View more papers